Werner Lanthaler

CEO

Evotec

Dr Werner Lanthaler is the Chief Executive Officer of Evotec, a drug discovery alliance and development partnership company, focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Previously he was Chief Financial Officer at Intercell AG, which developed from a venture-backed biotechnology company into a global vaccine player. He serves on the Board of Directors of AC Immune SA, is a Non-Executive Director and Chairman of the Audit Committee for arGEN-X SE and is on the Supervisory Board of Topas Therapeutics GmbH. He holds a doctorate in economics from Vienna University, earned his Master’s degrees from Harvard University, and holds a degree in Psychology.